NDC 69101-525

Conjupri

Levamlodipine Maleate

Conjupri is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Burke Therapeutics, Llc. The primary component is Levamlodipine Maleate.

Product ID69101-525_aee6ada0-652f-bbf9-e053-2a95a90a6c45
NDC69101-525
Product TypeHuman Prescription Drug
Proprietary NameConjupri
Generic NameLevamlodipine Maleate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-09-01
Marketing CategoryNDA / NDA
Application NumberNDA212895
Labeler NameBurke Therapeutics, LLC
Substance NameLEVAMLODIPINE MALEATE
Active Ingredient Strength3 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69101-525-30

30 TABLET in 1 BOTTLE (69101-525-30)
Marketing Start Date2020-09-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Conjupri" or generic name "Levamlodipine Maleate"

NDCBrand NameGeneric Name
24075-0410Conjuprilevamlodipine
24075-0411Conjuprilevamlodipine
24075-0412Conjuprilevamlodipine
24075-0413Conjuprilevamlodipine
66992-425Conjuprilevamlodipine
66992-430Conjuprilevamlodipine
69101-512Conjuprilevamlodipine maleate
69101-525Conjuprilevamlodipine maleate
69101-550Conjuprilevamlodipine maleate

Trademark Results [Conjupri]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CONJUPRI
CONJUPRI
88716966 not registered Live/Pending
Conjupro Biotherapeutics Inc.
2019-12-05
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.